Researchers have discovered that patents with Gorlin-Goltz syndrome have mutations in the PTCH1 gene, and the immunohistochemical results suggested that the OKC and POKC lesions were caused by a genetic alteration in the patients’ PTCH1-GLI gene [10]. Here, PTCH1 is linked to nevoid basal cell carcinoma syndrome.